Tag: Takhzyro

Takeda Receives Positive CHMP Opinion for Pre-Filled Syringe Presentation of TAKHZYRO® (lanadelumab) for Use as a Preventive Treatment for Hereditary Angioedema Attacks

May 29, 2020 Off

Takeda Receives Positive CHMP Opinion for Pre-Filled Syringe Presentation of TAKHZYRO® (lanadelumab) for Use as a Preventive Treatment for Hereditary Angioedema Attacks

By BusinessWire

Validation of Type II Variation will allow Takeda to commence launches in Europe later this year The pre-filled syringe presentation…

Shire nets European approval for Takhzyro, which can prevent potentially deadly hereditary angiodema

November 30, 2018 Off

Shire nets European approval for Takhzyro, which can prevent potentially deadly hereditary angiodema

By Dino Mustafić

Shire got the good news from the European Commission (EC) for Marketing Authorisation for Takhzyro injection, for prevention of recurrent…